FGFR4 and neoplasm: Accordingly, we detected shorter overall survival of the FGFR4high patient subgroups from several datasets, and FGFR4-KD(K504M) tumor-bearing mice survived significantly longer as compared to endogenously FGFR4high control xenografts.